Applied DNA Sciences (APDN) (Twitter: @APDN), a provider oApplied DNA Sciences (APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain and product authentication solutions, joined the Russell Microcap® Index at the conclusion of the Russell indexes annual reconstitution on June 26.
Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
James Hayward, President and Chief Executive Officer of Applied DNA Sciences, said, "We believe inclusion in the Russell Microcap Index will increase our recognition in the financial community. We are pleased with our Company's growth over the past year, the continued recognition we have received for our products on a global basis, and now with the recognition we receive by being included in the Russell Microcap Index."
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $5.7 trillion in assets are benchmarked to the Russell's U.S. indexes. Russell Indexes are part of FTSE Russell, a leading global index provider.
In that case. APDN hit jackpot since they are going to get mandate expansion too.
The significant drop is because last year it was not in house marking.this year it us in house markinh.charges are lesss
Why should it be confidential if it is about cancellation. There is no financial information in it.
Its good. May not be very good. Something like initial contract worth $350000 signed up with so and so community for marking household items.....
submitted an application under Rule 24b - 2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q on May 11 , 2015.
Based on representations by Applied DNA Sciences , Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period (s) specified:
Exhibit 10.1 through March 25, 2017